328 related articles for article (PubMed ID: 35883540)
21. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
Takaori K; Yanagita M
Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
[TBL] [Abstract][Full Text] [Related]
22. TIMP2 mediates endoplasmic reticulum stress contributing to sepsis-induced acute kidney injury.
Jiang N; Huang R; Zhang J; Xu D; Li T; Sun Z; Su L; Peng Z
FASEB J; 2022 Apr; 36(4):e22228. PubMed ID: 35218571
[TBL] [Abstract][Full Text] [Related]
23. Autophagy and Acute Kidney Injury.
Cui J; Bai X; Chen X
Adv Exp Med Biol; 2020; 1207():469-480. PubMed ID: 32671769
[TBL] [Abstract][Full Text] [Related]
24. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
25. Rodent models of AKI-CKD transition.
Fu Y; Tang C; Cai J; Chen G; Zhang D; Dong Z
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1098-F1106. PubMed ID: 29949392
[TBL] [Abstract][Full Text] [Related]
26. Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury.
Uddin MJ; Dorotea D; Pak ES; Ha H
Biomol Ther (Seoul); 2020 May; 28(3):213-221. PubMed ID: 32336052
[TBL] [Abstract][Full Text] [Related]
27. Targeting Endoplasmic Reticulum for Novel Therapeutics and Monitoring in Acute Kidney Injury.
Li C; Krothapalli S; Chen YM
Nephron; 2023; 147(1):21-24. PubMed ID: 36116429
[TBL] [Abstract][Full Text] [Related]
28. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation.
Nishida K; Watanabe H; Murata R; Tokumaru K; Fujimura R; Oshiro S; Nagasaki T; Miyahisa M; Hiramoto Y; Nosaki H; Imafuku T; Maeda H; Fukagawa M; Maruyama T
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070521
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
[TBL] [Abstract][Full Text] [Related]
30. The role of IL-10 in kidney disease.
Wei W; Zhao Y; Zhang Y; Jin H; Shou S
Int Immunopharmacol; 2022 Jul; 108():108917. PubMed ID: 35729842
[TBL] [Abstract][Full Text] [Related]
31. An acute phase protein α
Watanabe H; Fujimura R; Hiramoto Y; Murata R; Nishida K; Bi J; Imafuku T; Komori H; Maeda H; Mukunoki A; Takeo T; Nakagata N; Tanaka M; Matsushita K; Fukagawa M; Maruyama T
Sci Rep; 2021 Apr; 11(1):7953. PubMed ID: 33846468
[TBL] [Abstract][Full Text] [Related]
32. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
Li C; Xie N; Li Y; Liu C; Hou FF; Wang J
Free Radic Biol Med; 2019 Jan; 130():512-527. PubMed ID: 30447351
[TBL] [Abstract][Full Text] [Related]
33. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
Zhang X; Agborbesong E; Li X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
[TBL] [Abstract][Full Text] [Related]
34. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
[TBL] [Abstract][Full Text] [Related]
35. Identification and activation of Src family kinases in primary megakaryocytes.
Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
[TBL] [Abstract][Full Text] [Related]
36. The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.
Liang Y; Qu L; Liu Z; Liang L; Wang Y; Quan S; Wang Y; Tang L
Mol Biol Rep; 2022 Aug; 49(8):7709-7718. PubMed ID: 35696049
[TBL] [Abstract][Full Text] [Related]
37. The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis.
Guo R; Duan J; Pan S; Cheng F; Qiao Y; Feng Q; Liu D; Liu Z
Cell Death Dis; 2023 Jul; 14(7):426. PubMed ID: 37443140
[TBL] [Abstract][Full Text] [Related]
38. Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
Ó hAinmhire E; Humphreys BD
Nephron; 2017; 137(4):264-267. PubMed ID: 28595180
[TBL] [Abstract][Full Text] [Related]
39. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
Chou YH; Chu TS; Lin SL
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
[TBL] [Abstract][Full Text] [Related]
40. The Nephroprotective Effect of MS-275 on Lipopolysaccharide (LPS)-Induced Acute Kidney Injury by Inhibiting Reactive Oxygen Species (ROS)-Oxidative Stress and Endoplasmic Reticulum Stress.
Zhang H; Zhang W; Jiao F; Li X; Zhang H; Wang L; Gong Z
Med Sci Monit; 2018 Apr; 24():2620-2630. PubMed ID: 29704392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
